Sequences reported in this paper have been deposited in GenBank with Accession Number U22106.Abbreviations: (-+)-6,7-ADTN, 6,7-dihyroxy-2-aminotetralin; CY 208 243, (-)-4,6,6a,7,8, 12b-hexahydro-7-methyl-indolo[4,3-ab]-phenanthridine; DA, dopamine; DHA, dihydroalprenolol; 8-OH-DPAT, (+)-8-hydroxy-N, N-dipropyl-2-aminotetralin; 5-HT, serotonin (5-hydroxytryptamine); L-dopa, L-3,4-dihydroxphenylalanine; LSD, lysergic acid diethylamine; NE, norepinephrine; N(-)-NPA, N-propyl-norapomorphine; SCH-23390, (R)-(+) -7-chloro-8-hydroxy-3-methyl-l-phenyl-2,3,4,5-tetrahydro-lH-3-benzazepine; SKF-38393, 2,3,4,5-tetrahydro-7,8-dihydroxy-l-phenyl-lH-3-benzazepine; SKF-81927, 6-chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine; SKF-82526, 6-chloro-7,8-dihydroxy-1 -(p-hydroxyphenyl)-2,3,4,5-tetrahydro-(1H)-3-benzazepine; TM, transmembrane; WB-4101, 2-(2,6-dimethoxyphenoxyethyl)aminomethyl-l,4-benzodioxane; YM-09151-2, eis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylamino-benzamide. cific motifs or amino acid residues confering high affinity benzazepine receptor interactions.